Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
CJC-1295 has reached phase 2 trials, but development was discontinued following a fatal myocardial infarction in a participant shortly after their 11th dose of CJC-1295 [8, 9]
Some people maintain their energy boost for weeks, while others need more frequent injections.
Until rigorous, randomized, placebo-controlled trials are conducted and published, the responsible position is to rely on proven, evidence-based approaches to recovery and healing, and to leave unapproved peptides where they belong for now: in the laboratory, not in your body.
Adeghate E, et al
, TB-500, - , ,
US$ 21.22
US$ 22.48
US$ 23.27
